SCHEMBL10140623

SCHEMBL10140623

CCC(=O)C(C)(C)c1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.42
RIPK1 Q13546 2/20 0.41
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
DRD2 P14416 1/20 0.37
OPRM1 P35372 1/20 0.37
DRD3 P35462 1/20 0.37
ESR2 Q92731 1/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8915396 0.84 KCNN4 (0.41) KCNN4RIPK1HDAC3HDAC1HDAC2
SCHEMBL19578315 0.84 KCNN4 (0.41) KCNN4RIPK1HDAC3HDAC1HDAC2
SCHEMBL25260011 0.81 CES2 (0.40) RIPK1NPSR1DRD2OPRM1DRD3
SCHEMBL12516818 0.79 GABRA1 (0.38) NPSR1DRD2OPRM1DRD3CES2
SCHEMBL1239901 0.79 KCNN4 (0.50) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL12841736 0.79 KCNN4 (0.46) KCNN4RIPK1HDAC3HDAC1HDAC2
SCHEMBL30501782 0.79 KCNN4 (0.50) KCNN4HDAC3HDAC1HDAC2HDAC6
SCHEMBL19733612 0.78 ALDH1A1 (0.40) DRD2OPRM1DRD3CES2CES1
SCHEMBL18113457 0.77 PIN1 (0.45) NPSR1CYP2C19
SCHEMBL30603802 0.77 PIN1 (0.45) NPSR1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021704-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
WO-2011081918-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-07-07 WO disclosed
WO-2011031904-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-03-17 WO disclosed
WO-2011031934-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-03-17 WO disclosed
WO-2010148006-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2010-12-23 WO disclosed
WO-2010096462-A1 LINKED DIIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC (US) 2010-08-26 WO disclosed
WO-2010091413-A1 LINKED DIBENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. (US) 2010-08-12 WO disclosed